134 related articles for article (PubMed ID: 16861552)
1. Double hepatic arterial phase MRI of the liver with switching of reversed centric and centric K-space reordering.
Kanematsu M; Goshima S; Kondo H; Yokoyama R; Kajita K; Hoshi H; Onozuka M; Nozaki A; Hirano M; Shiratori Y; Moriyama N
AJR Am J Roentgenol; 2006 Aug; 187(2):464-72. PubMed ID: 16861552
[TBL] [Abstract][Full Text] [Related]
2. Optimal acquisition delay for dynamic contrast-enhanced MRI of hypervascular hepatocellular carcinoma.
Goshima S; Kanematsu M; Kondo H; Shiratori Y; Onozuka M; Moriyama N; Bae KT
AJR Am J Roentgenol; 2009 Mar; 192(3):686-92. PubMed ID: 19234264
[TBL] [Abstract][Full Text] [Related]
3. High-resolution double arterial phase hepatic MRI using adaptive 2D centric view ordering: initial clinical experience.
Low RN; Bayram E; Panchal NJ; Estkowski L
AJR Am J Roentgenol; 2010 Apr; 194(4):947-56. PubMed ID: 20308496
[TBL] [Abstract][Full Text] [Related]
4. Dual double arterial phase dynamic MR imaging with sensitivity encoding (SENSE): which is better for diagnosing hypervascular hepatocellular carcinomas, in-phase or opposed-phase imaging?
Yoshioka H; Sato J; Takahashi N; Lou D; Yamaguchi M; Saida Y; Itai Y
Magn Reson Imaging; 2004 Apr; 22(3):361-7. PubMed ID: 15062931
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of optimal scan delay for gadoxetate disodium-enhanced hepatic arterial phase MRI using MR fluoroscopic triggering and slow injection technique.
Goshima S; Kanematsu M; Kondo H; Watanabe H; Kawada H; Moriyama N; Bae KT
AJR Am J Roentgenol; 2013 Sep; 201(3):578-82. PubMed ID: 23971449
[TBL] [Abstract][Full Text] [Related]
6. MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases.
Goshima S; Kanematsu M; Kondo H; Yokoyama R; Miyoshi T; Nishibori H; Kato H; Hoshi H; Onozuka M; Moriyama N
AJR Am J Roentgenol; 2006 Jul; 187(1):W25-32. PubMed ID: 16794136
[TBL] [Abstract][Full Text] [Related]
7. Timing of the hepatic arterial phase at Gd-EOB-DTPA-enhanced hepatic dynamic MRI: comparison of the test-injection and the fixed-time delay method.
Nakamura S; Nakaura T; Kidoh M; Utsunomiya D; Doi Y; Harada K; Uemura S; Yamashita Y
J Magn Reson Imaging; 2013 Sep; 38(3):548-54. PubMed ID: 23744782
[TBL] [Abstract][Full Text] [Related]
8. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session].
Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK
Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745
[TBL] [Abstract][Full Text] [Related]
9. Normal dynamic MRI enhancement patterns of the upper abdominal organs: gadoxetic acid compared with gadobutrol.
Kühn JP; Hegenscheid K; Siegmund W; Froehlich CP; Hosten N; Puls R
AJR Am J Roentgenol; 2009 Nov; 193(5):1318-23. PubMed ID: 19843748
[TBL] [Abstract][Full Text] [Related]
10. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.
Frericks BB; Loddenkemper C; Huppertz A; Valdeig S; Stroux A; Seja M; Wolf KJ; Albrecht T
AJR Am J Roentgenol; 2009 Oct; 193(4):1053-60. PubMed ID: 19770329
[TBL] [Abstract][Full Text] [Related]
11. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
12. Hepatic MR imaging with a dynamic contrast-enhanced isotropic volumetric interpolated breath-hold examination: feasibility, reproducibility, and technical quality.
Lee VS; Lavelle MT; Rofsky NM; Laub G; Thomasson DM; Krinsky GA; Weinreb JC
Radiology; 2000 May; 215(2):365-72. PubMed ID: 10796909
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced timing robust acquisition order with a preparation of the longitudinal signal component (CENTRA plus) for 3D contrast-enhanced abdominal imaging.
Beck GM; De Becker J; Jones AC; von Falkenhausen M; Willinek WA; Gieseke J
J Magn Reson Imaging; 2008 Jun; 27(6):1461-7. PubMed ID: 18504734
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience.
Lauenstein TC; Salman K; Morreira R; Heffron T; Spivey JR; Martinez E; Sharma P; Martin DR
AJR Am J Roentgenol; 2007 Sep; 189(3):663-70. PubMed ID: 17715115
[TBL] [Abstract][Full Text] [Related]
15. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
[TBL] [Abstract][Full Text] [Related]
16. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
[TBL] [Abstract][Full Text] [Related]
17. The usefulness of 1.5 harmonic imaging ultrasonography with Levovist in the diagnosis of focal hepatic tumors.
Yamamoto K; Shiraki K; Nakanishi S; Fuke H; Hashimoto A; Shimizu A; Nakano T
Int J Oncol; 2005 Oct; 27(4):989-95. PubMed ID: 16142315
[TBL] [Abstract][Full Text] [Related]
18. Optimal scan timing of hepatic arterial-phase imaging of hypervascular hepatocellular carcinoma determined by multiphasic fast CT imaging technique.
Kagawa Y; Okada M; Yagyu Y; Kumano S; Kanematsu M; Kudo M; Murakami T
Acta Radiol; 2013 Oct; 54(8):843-50. PubMed ID: 23761547
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI.
Choi SH; Lee JM; Yu NC; Suh KS; Jang JJ; Kim SH; Choi BI
AJR Am J Roentgenol; 2008 Aug; 191(2):529-36. PubMed ID: 18647927
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium-enhanced MR imaging of the liver: optimizing imaging delay for hepatic arterial and portal venous phases--a prospective randomized study in patients with chronic liver damage.
Kanematsu M; Semelka RC; Matsuo M; Kondo H; Enya M; Goshima S; Moriyama N; Hoshi H
Radiology; 2002 Nov; 225(2):407-15. PubMed ID: 12409573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
